NASDAQ:SIOX Sio Gene Therapies (SIOX) Stock Price, News & Analysis → Warning: this could blow your mind (From DTI) (Ad) Free SIOX Stock Alerts $0.48 +0.01 (+1.70%) (As of 02/7/2024) Add Compare Share Share Today's Range$0.45▼$0.4850-Day Range$0.38▼$0.4852-Week Range$0.25▼$0.50Volume40,400 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsSEC FilingsSocial MediaStock AnalysisChartFinancialsSEC FilingsSocial Media Get Sio Gene Therapies alerts: Email Address Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. About Sio Gene Therapies Stock (NASDAQ:SIOX)Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical School to develop and commercialize gene therapy product candidates, including AXO-AAV-GM1 and AXO-AAV-GM. The company was formerly known as Axovant Gene Therapies Ltd. and changed its name to Sio Gene Therapies, Inc. in November 2020. Sio Gene Therapies, Inc. was incorporated in 2014 and is based in New York, New York.Read More SIOX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SIOX Stock News HeadlinesFebruary 2, 2024 | finance.yahoo.comSio Gene Therapies, Inc. to File for Dissolution and Declare an Initial Liquidating Distribution of $0.435 Per ShareNovember 22, 2023 | morningstar.comSio Gene Therapies Inc SIOXMarch 29, 2024 | WealthPress (Ad)$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…November 1, 2023 | thestreet.comTwo Promising Gene Therapy Stocks Tackling Eye DiseaseJuly 19, 2023 | fool.comSio Gene Therapies (NASDAQ: AXGT)July 13, 2023 | finance.yahoo.comRoivant in Talks to Sell Stomach Drug to Roche in Deal Valued at More Than $7 BillionMay 23, 2023 | nbcnews.comA new gene therapy could be a game-changer for patients with severe anemia. The cost? $2.8 million.February 14, 2023 | finance.yahoo.comSio Gene Therapies Announces Fiscal Third Quarter 2022 Financial ResultsMarch 29, 2024 | Crypto Swap Profits (Ad)Did You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.January 26, 2023 | seekingalpha.comSIOX Sio Gene Therapies Inc.December 14, 2022 | finance.yahoo.comSio Gene Therapies Inc. Announces Board Approval of Plan of Complete Liquidation and DissolutionNovember 10, 2022 | bizjournals.comFollowing layoffs, gene therapy firm leaves DurhamNovember 10, 2022 | finance.yahoo.comSio Gene Therapies Announces Fiscal Second Quarter 2022 Financial ResultsOctober 31, 2022 | finance.yahoo.comSio Gene Therapies (NASDAQ:SIOX) Will Have To Spend Its Cash WiselyAugust 11, 2022 | finance.yahoo.comSio Gene Therapies Announces Fiscal First Quarter 2022 Financial ResultsAugust 5, 2022 | uk.finance.yahoo.comSio Gene Therapies Inc. (SIOX)June 14, 2022 | bizjournals.comGene therapy firm in Durham slashes headcount as biotech stumblesJune 14, 2022 | finance.yahoo.comSio Gene Therapies Announces Fiscal Year 2021 Year-End Financial ResultsApril 28, 2022 | markets.businessinsider.comMid-Afternoon Market Update: Nasdaq Jumps 400 Points; Sio Gene Therapies Shares PlummetApril 28, 2022 | finance.yahoo.comSio Gene Therapies Ditches Two Remaining Programs, Seeks Buyer(s), Shares PlungeApril 27, 2022 | finance.yahoo.comSio Gene Therapies Provides Corporate UpdateFebruary 11, 2022 | finance.yahoo.comSio Gene Therapies Announces Corporate Updates and Fiscal Third Quarter 2021 Financial ResultsFebruary 2, 2022 | benzinga.comSVB Leerink Downgrades Sio Gene Therapies to Market Perform, Lowers Price Target to $1February 1, 2022 | benzinga.comHC Wainwright & Co. Maintains Buy on Sio Gene Therapies, Lowers Price Target to $7February 1, 2022 | msn.comThe Daily Biotech Pulse: ImmunityBio Reports Positive Readout, Valneva Starts Late-Stage Chikungunya Vaccine Study, Sio Gene Shelves Parkinson's ProgramJanuary 4, 2022 | nasdaq.comCompanies Like Sio Gene Therapies (NASDAQ:SIOX) Are In A Position To Invest In GrowthNovember 12, 2021 | finance.yahoo.comWe're Hopeful That Sio Gene Therapies (NASDAQ:SIOX) Will Use Its Cash WiselySee More Headlines Receive SIOX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sio Gene Therapies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/12/2021Today3/29/2024Fiscal Year End3/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:SIOX CUSIPN/A CIK1636050 Websiogtx.com Phone(646) 677-6770FaxN/AEmployees12Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.83 per share Price / Book0.58Miscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNo Data Beta1.14 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. David W. Nassif J.D. (Age 70)CEO, CFO, Chief Accounting Officer, General Counsel & Director Comp: $699.52kKey CompetitorsGrifolsNASDAQ:GRFSLAVA TherapeuticsNASDAQ:LVTXMainz BiomedNASDAQ:MYNZNLS PharmaceuticsNASDAQ:NLSPPharvarisNASDAQ:PHVSView All Competitors SIOX Stock Analysis - Frequently Asked Questions How have SIOX shares performed in 2024? Sio Gene Therapies' stock was trading at $0.37 on January 1st, 2024. Since then, SIOX stock has increased by 29.2% and is now trading at $0.4780. View the best growth stocks for 2024 here. How were Sio Gene Therapies' earnings last quarter? Sio Gene Therapies Inc. (NASDAQ:SIOX) posted its quarterly earnings data on Friday, November, 12th. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.17) by $0.12. When did Sio Gene Therapies' stock split? Sio Gene Therapies's stock reverse split on the morning of Wednesday, May 8th 2019. The 1-8 reverse split was announced on Tuesday, May 7th 2019. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, May 7th 2019. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split. How do I buy shares of Sio Gene Therapies? Shares of SIOX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:SIOX) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryOnly a fool would buy Nvidia today… Porter & CompanyAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sio Gene Therapies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.